Alkahest
Shreya Chand is a scientist at Alkahest, Inc. since March 2017, specializing in proteomics and biological mass spectrometry. Prior to this role, Shreya served as a Research Specialist at the UCSF Mass Spectrometry Facility from November 2012 to December 2016. Shreya's academic journey includes a PhD in Bioanalytical Chemistry from Rensselaer Polytechnic Institute, earned between 2006 and 2012, supplemented by a Master of Science in Chemistry and a Bachelor of Science in Chemistry from Delhi University, completed in 2005 and 2003, respectively.
Alkahest
Alkahest is developing therapies derived from blood to treat neurological diseases, with an emphasis on the age-related cognitive decline - key medical challenges of our generation.